1. |
Abraham AG, Althoff KN, Jing Y, et al. End-stage renal disease among HIV-infected adults in North America. Clin Infect Dis, 2015, 60(6): 941-949.
|
2. |
Tang SCW, Lai KN. Peritoneal dialysis: the ideal bridge from conservative therapy to kidney transplant. J Nephrol, 2020, 33(6): 1189-1194.
|
3. |
Brown MC, Simpson K, Kerssens JJ, et al. Peritoneal dialysis-associated peritonitis rates and outcomes in a national cohort are not improving in the post-millennium (2000-2007). Perit Dial Int, 2011, 31(6): 639-650.
|
4. |
国家疾病预防控制局. 2021年全国法定传染病疫情概况. Available at: http://www.nhc.gov.cn/jkj/s3578/202204/4fd88a291d914abf8f7a91f6333567e1.shtml.
|
5. |
Heron JE, Bagnis CI, Gracey DM. Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV. AIDS Res Ther, 2020, 17(1): 11.
|
6. |
Ryom L, Kirk O, Lundgren JD, et al. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe. HIV Med, 2013, 14(8): 503-508.
|
7. |
Ndlovu KC, Sibanda W, Assounga A. Peritonitis outcomes in patients with HIV and end-stage renal failure on peritoneal dialysis: a prospective cohort study. BMC Nephrol, 2017, 18(1): 48.
|
8. |
王珍燕, 沈银忠, 张仁芳, 等. 110例人类免疫缺陷病毒感染及获得性免疫缺陷综合征患者合并血小板减少症临床分析. 内科理论与实践, 2013, 8(2): 106-110.
|
9. |
Yang Y, Yuan J, Liu L, et al. Platelet-to-albumin ratio: a risk factor associated with technique failure and mortality in peritoneal dialysis patients. Ren Fail, 2021, 43(1): 1359-1367.
|
10. |
Xu LC, Zhou FF, Li M, et al. Predictive value of peripheral blood neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on patient survival with peritoneal dialysis. Clin Lab, 2021, 67(9): 210124.
|
11. |
Zhu Y, Peng F, Chen Y, et al. Mean platelet volume/platelet count ratio and mortality in patients on peritoneal dialysis. Clin Nephrol, 2018, 90(3): 205-211.
|